ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012

SEER Data Show Under Age 55 Death Rates are Decreasing, Mixed Results In Various Categories

December 12, 1986

Clinical Trials Approved By NCI

November 28, 2003

Oncology ManagementL AOR earns $30 Million, PRN Earns $29.8 Million

March 5, 1999

New Community Control Program May Be Developed

October 24, 1975

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982